TS-134, multiple dose, titration
Showing 1 - 25 of >10,000
Healthy Adult Subjects Trial in Toshima-ku (TS-172, Placebo)
Completed
- Healthy Adult Subjects
- TS-172
- Placebo
-
Toshima-ku, JapanTaisho Pharmaceutical Co., Ltd selected site
Apr 11, 2022
Healthy Volunteer Trial in Shinjuku-ku (TAK-935, Placebo)
Completed
- Healthy Volunteer
- TAK-935
- Placebo
-
Shinjuku-ku, Tokyo, JapanClinical Research Hospital Tokyo
Nov 10, 2021
Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))
Recruiting
- Progressive Multiple Sclerosis
- Placebo
- Masitinib (4.5)
-
Lille, France
- +1 more
Jul 1, 2022
Healthy, Obesity Trial (BI 1820237, semaglutide, Placebo)
Not yet recruiting
- Healthy
- Obesity
- BI 1820237
- +3 more
- (no location specified)
Mar 6, 2023
Obesity Trial in Mainz, Neuss (BI 456906, Placebo)
Completed
- Obesity
- BI 456906
- Placebo
-
Mainz, Germany
- +1 more
Mar 18, 2021
Healthy Volunteers Trial in Glendale (TS-134, Placebo)
Completed
- Healthy Volunteers
- TS-134
- Placebo
-
Glendale, CaliforniaPAREXEL - Early Phase Clinical Unit-Los Angeles
Nov 14, 2018
Atopic Dermatitis, Psoriasis, Asthma Trial in United Kingdom (EDP1867, Placebo)
Completed
- Atopic Dermatitis
- +2 more
- EDP1867
- Placebo
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Oct 6, 2022
Diabetes, Type 2 Trial in Cheng Du, Beijing (Tirzepatide, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Tirzepatide
- Placebo
-
Cheng Du, Sichuan, China
- +1 more
Aug 23, 2021
Healthy Volunteers Trial in Glendale (TS-161, TS-161 Placebo)
Completed
- Healthy Volunteers
- TS-161
- TS-161 Placebo
-
Glendale, CaliforniaPAREXEL - Early Phase Clinical Unit-Los Angeles
Feb 26, 2020
Psoriasis, Atopic Dermatitis Trial in United Kingdom (EDP1066, Placebo oral capsule)
Completed
- Psoriasis
- Atopic Dermatitis
- EDP1066
- Placebo oral capsule
-
Guildford, Surrey, United Kingdom
- +6 more
Nov 8, 2021
Diabetes Type 2 - Insulin-Treated Trial in Pittsburgh (Smartphone application and web portal, Standard Insulin Therapy
Active, not recruiting
- Diabetes Mellitus Type 2 - Insulin-Treated
- Smartphone application and web portal
- Standard Insulin Therapy Education
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Jan 6, 2023
Multiple Sclerosis, Transcranial Direct Current Stimulation Trial in Istanbul (Transcutaneous Spinal Direct Current Stimulation)
Recruiting
- Multiple Sclerosis
- Transcranial Direct Current Stimulation
- Transcutaneous Spinal Direct Current Stimulation
-
Istanbul, Kadıköy, TurkeyCadde Tıp Merkezi
Oct 31, 2023
Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)
Completed
- Healthy Subjects
- +2 more
- HEC88473 injection
- Placebo
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jul 14, 2023
Chronic Kidney Disease Trial in Multiple Locations (TS-143)
Completed
- Chronic Kidney Disease
-
Multiple Locations, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 4, 2022
Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers Trial in Overland Park (TMP-301, Placebo)
Active, not recruiting
- Cocaine Use Disorder
- +2 more
- TMP-301
- Placebo
-
Overland Park, KansasAltasciences
Aug 29, 2023
Candidiasis, Chronic Mucocutaneous Trial run by the Matinas BioPharma Nanotechnologies, Inc. (Amphotericin B)
Completed
- Candidiasis, Chronic Mucocutaneous
- Amphotericin B
-
Bethesda, MarylandNational Institute of Allergy and Infectious Disease (NIAID)
Aug 17, 2022
Diabetic Macular Edema Trial in Beijing (ASKG712)
Not yet recruiting
- Diabetic Macular Edema
- ASKG712
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Jul 12, 2023
Healthy Male Subjects Trial in Tokyo ([14C] TS-142)
Completed
- Healthy Male Subjects
- [14C] TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Phenylketonurias Trial in Aurora (RTX-134)
Active, not recruiting
- Phenylketonurias
-
Aurora, ColoradoChildren's Hospital Colorado
Jan 6, 2022